Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373794

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373794

Global Pain Management Market Size, Share, Growth Analysis, By Application (Neuropathic pain, cancer pain), By Distribution Channel(Online pharmacy, retail pharmacy) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Pain Management Market size was valued at USD 72.1 Billion in 2021 and is poised to grow from USD 75.20 Billion in 2022 to USD 105.32 Billion by 2030, at a CAGR of 4.3% during the forecast period (2023-2030).

The global pain management market has experienced substantial expansion due to the rising prevalence of chronic pain conditions, including arthritis, cancer pain, neuropathic pain, and musculoskeletal disorders. This surge in chronic pain cases has driven demand for effective pain relief solutions. Advancements in pain management technologies, such as novel pharmaceuticals, medical devices, and minimally invasive procedures, along with the integration of advanced technologies like neuromodulation and targeted drug delivery systems, have broadened the range of effective treatment options. However, challenges exist, including concerns about opioid abuse and addiction, which have prompted stricter regulations and a shift toward non-opioid alternatives for pain management, thereby presenting healthcare providers and pharmaceutical companies with the task of balancing pain relief needs with potential risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global pain management market is segmented on the basis of application, distribution channel, and region. By application, the market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications. By distribution channel, the market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Awareness and Focus on Pain Management

A heightened understanding of pain's profound influence on people's well-being is prompting healthcare providers, patients, and policymakers to prioritize pain management, resulting in intensified research, education, and enhanced access to efficient pain relief. This emphasis on patient-centered care and better pain management outcomes is propelling the market forward.

Rising Geriatric Population

The pain management market is being notably influenced by the aging population, given that older adults are at a higher risk of experiencing chronic pain issues like osteoarthritis and neuropathic pain. As the world experiences a growing trend of aging demographics, the need for pain management solutions is on the rise, as elderly individuals actively seek efficient ways to alleviate pain and sustain their overall well-being and autonomy.

Restraints:

High Cost of Pain Management Treatments

The growth of the market for pain management treatments can be impeded by the high costs associated with advanced procedures and devices, which may hinder access for specific patient groups, especially in low-income regions or countries with limited healthcare resources. The expenses related to medications, surgical interventions, and specialized therapies pose a significant barrier to broader market expansion.

Regulatory and Reimbursement Challenges

The pain management industry is influenced by regulatory stipulations and reimbursement obstacles that can impede its expansion. Regulatory factors, such as constraints on opioid prescription and medical device regulations, play a pivotal role in shaping the accessibility of pain management solutions. Additionally, reimbursement policies and constraints can impact the adoption and utilization of specific pain management treatments.

Market Trends:

The current trend in pain management involves a growing focus on multimodal, personalized approaches that encompass a range of therapies and interventions to address pain comprehensively. This includes a combination of pharmaceutical treatments, non-pharmacological therapies, physical therapy, psychological interventions, and lifestyle modifications, all tailored to the specific needs of each patient, considering factors like the pain's underlying cause, comorbidities, and patient preferences. Additionally, minimally invasive procedures for pain relief, such as nerve blocks, radiofrequency ablation, and spinal cord stimulation, are becoming increasingly popular due to their targeted pain relief, reduced invasiveness, shorter recovery periods, and potential for fewer side effects when compared to traditional surgical methods, driven by advancements in medical technology and healthcare professionals' growing expertise.

Product Code: SQMIG35I2178

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Pain Management Market by Application
    • Market Overview
    • Neuropathic pain
    • cancer pain
    • facial pain and migraine
    • musculoskeletal pain
    • and other applications
  • Global Pain Management Market by Distribution Channel
    • Market Overview
    • Online pharmacy
    • retail pharmacy
    • and hospital pharmacy
  • Global Pain Management Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Johnson & Johnson - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novartis International AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • GlaxoSmithKline PLC - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AbbVie Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AstraZeneca PLC - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. - Israel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi S.A. - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bristol Myers Squibb Company - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic PLC - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boston Scientific Corporation - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • St. Jude Medical, Inc. (Abbott) - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stryker Corporation - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cardinal Health, Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Halyard Health (O&M Halyard) - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mallinckrodt Pharmaceuticals - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!